River Blindness News and Research

RSS
River Blindness or onchocerciasis is caused by the prelarval (microfilaria) and adult stages of the filarial nematode Onchocerca volvulus. The disease is transmitted by the bite of certain species of female Simulium flies (black flies) that bite by day and are found near rapidly flowing rivers and streams. Onchocerciasis is endemic in more than 25 nations located in a broad band across the central part of Africa. Small endemic foci are also present in the Arabian Peninsula (Yemen) and in the Americas (Brazil, Colombia, Ecuador, Guatemala, southern Mexico, and Venezuela)
Colombia, Mexico, Guatemala make progress against river blindness

Colombia, Mexico, Guatemala make progress against river blindness

Burundi makes significant progress against NTDs

Burundi makes significant progress against NTDs

Disease mapping could help control and eliminate loiasis, other NTDs, study says

Disease mapping could help control and eliminate loiasis, other NTDs, study says

Ivermectin cream demonstrates activity against head lice eggs

Ivermectin cream demonstrates activity against head lice eggs

MSU professor focuses on new formulation for old drug to treat parasitic diseases

MSU professor focuses on new formulation for old drug to treat parasitic diseases

Mass administration of common anti-parasitic is possible new tool in fight against malaria

Mass administration of common anti-parasitic is possible new tool in fight against malaria

Heartworm medication Ivermectin prevents malaria transmission in Africa

Heartworm medication Ivermectin prevents malaria transmission in Africa

Rinderpest - fatal animal disease eradicated

Rinderpest - fatal animal disease eradicated

FDA accepts Topaz's ivermectin NDA for treatment for head lice infestations

FDA accepts Topaz's ivermectin NDA for treatment for head lice infestations

GlobalPost examines Pres. Obama's Global Health Initiative

GlobalPost examines Pres. Obama's Global Health Initiative

Anacor Pharma, MMV enter agreement to develop AN3661 for malaria treatment

Anacor Pharma, MMV enter agreement to develop AN3661 for malaria treatment

Anacor and iOWH establish research agreement to identify new drugs for shigellosis

Anacor and iOWH establish research agreement to identify new drugs for shigellosis

Scientist receives grant for research on parasitic diseases through African biodiversity medicines

Scientist receives grant for research on parasitic diseases through African biodiversity medicines

Antibiotic treatment may be sufficient to overcome River Blindness

Antibiotic treatment may be sufficient to overcome River Blindness

Opinions: Kangaroo care; NTDs, Women's health

Opinions: Kangaroo care; NTDs, Women's health

Three-day meeting on eliminating river blindness kicks off in Nigeria

Three-day meeting on eliminating river blindness kicks off in Nigeria

Anacor, UCSF and NYBC collaborate to discover drug therapies for river blindness

Anacor, UCSF and NYBC collaborate to discover drug therapies for river blindness

Report documents increase in R&D projects on developing world diseases

Report documents increase in R&D projects on developing world diseases

Carter Center, Merck take steps to prevent river blindness in Latin America

Carter Center, Merck take steps to prevent river blindness in Latin America

Discovery of anti-parasitic drug mechanism could lead to new treatments for filarial diseases

Discovery of anti-parasitic drug mechanism could lead to new treatments for filarial diseases